Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trastuzumab Rezetecan Plus Adebrelimab}
NCT07865611Phase 2Not yet recruiting
- Sponsor
- Tongji Hospital
- Start
- Sep 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Phase 2 trial, sponsored by Tongji Hospital. Planned start Sep 2026; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07865611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07865611.